# Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition

> **NCT02297854** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 83 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Valganciclovir Hydrochloride

## Key facts

- **NCT ID:** NCT02297854
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-08
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2014-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02297854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02297854, "Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02297854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*